COMMENTARY
Health care providers and patients became aware of the relationship between insulin, seizures, and coma almost with the advent of this miracle drug. In the findings of Frederick Banting's seminal paper on insulin, 1 he noted that rabbits given the pancreatic extract (insulin) became hyper-excitable and had clonic convulsive seizures lasting for several minutes. Banting concluded that, "subcutaneous injections of dextrose solutions antidote the convulsions and other symptoms, so that the animal (rabbit) in a few minutes becomes restored to a tolerably normal condition." In the late 1920s and early 1930s, Manfred Sakel and others used insulin in an innovative manner to treat patients with morphine withdrawal and other neuropsychiatric illness by inducing seizure and coma.
From 1930 to 1960, insulin coma therapy was performed on schizophrenic patients. Seizures occurred during these therapies ranging from total convulsions to only jerks and twitches. 2,3 By the end of this experience with therapy, the doctrine that insulin therapy could induce seizure was well established.
Hypoglycemia should be in the differential diagnosis of any individual with seizures. Because diabetes is a condition that typically uses hypoglycemia-causing agents (insulin and oral hypoglycemic agents in the sulfonylurea and meglitinide drug classes), it is important to be aware that seizures in this population could be iatrogenic.
The Diabetes Control and Complications Trial (DCCT) 4 reported the frequency of hypoglycemic "loss of consciousness" events in patients with type 1 diabetes. In the study's intensive therapy group, loss of consciousness events occurred at a rate of 16.3 episodes per 100 patient-years, which falls within the range of other reports. 4 Although there have been some reports of the frequency of insulin-induced unconsciousness events, validating the formal relationship in a clinical setting may be difficult for several reasons. First, seizures are not always witnessed and are often reported after the fact. In children, 75% of hypoglycemic seizures are reported as occurring at night. 5 Second, recording of blood Third, a long duration of diabetes is often accompanied by comorbid conditions associated with microvasular and macrovascular injuries. These injuries could be detrimental to nerve conduction and further confound the relationship between hypoglycemia, diabetes, and seizure. Finally, because of compensatory mechanisms in the body, particularly in type 2 diabetes, euglycemia or even hyperglycemia may occur during and after a seizure. These compensatory mechanisms make correlating the inciting hypoglycemic event difficult, even in a hospital setting. Although hypoglycemia can induce seizures, other etiologies of seizures should not be overlooked in the diabetic population. A large Australian regional diabetes center found that the prevalence of epilepsy in children with type 1 diabetes was similar to that in the general population and noted that health care providers should not assume that a seizure in a type 1 diabetic patient is the result of hypoglycemia. 6 Recently, continuous glucose monitoring (CGM) technology has allowed researchers to capture data furthering the understanding of hypoglycemia-induced seizures. Nighttime is the most vulnerable period for hypoglycemia because sleep blunts the counterregulatory responses to hypoglycemia, even in nondiabetic people. 7 Patients with diabetes who have had seizures while wearing a CGM device in some cases display a CGM reading of < 60 mg/dl for more than 2 hours before the seizure occurred. 5 The capturing of these seizure events on CGM suggests that several factors, including nocturnal timing, sleep status, and preceding duration of hypoglycemia, may be necessary to create the clinical event of a hypoglycemic seizure. Type 1 diabetes accounts for a small proportion of total diabetes prevalence worldwide. Patients with type 2 diabetes also may have seizures from hypoglycemia, but medical literature on the subject is scant. This further implies that, although seizures and comas can be induced with excess insulin, the frequency with which these events occur in the general diabetic population appears to be low.
After his seizure, A.S. was transferred to the hospital's intensive care unit. While there, he had an electroencephalogram that showed some abnormal conduction pathways. He was euglycemic for the remainder of his hospitalization, his nausea resolved, and his hydration and volume status normalized; he was discharged to home in his usual state of health.
Neither the neurology nor the endocrinology service unequivocally stated that hypoglycemia caused his seizure because of his confounding past alcohol abuse, metabolic derangements with end-stage renal disease, and previous stroke with residual tissue injury noted on magnetic resonance imaging. He will be evaluated as an outpatient for a newly identified seizure disorder. 
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